Intralipid infusion for 3 h significantly increased CTRP-2 levels in healthy control (P = 0.004) and PCOS (P = 0.02) women; but had no effects on CTRP-9, GDF-8 or GDF15 (Table 2). This evidence concerns the gene MSTN and polycystic ovary syndrome.